.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, using up the top science area at Sanofi.Quigley will start Sept. 30 as the French Big Pharma’s chief medical police officer and also worldwide director of research study, Sanofi said to Strong Biotech in an emailed statement.Quigley is actually replacing Frank Nestle, M.D., that left behind Sanofi this spring season in the middle of a global overhaul of the company’s R&D unit. Nestle, who devoted 8 years along with the pharma, dove over to Deerfield Administration, where he currently acts as a partner on the therapies team and also chief executive officer of the company’s therapeutic exploration as well as progression procedures.
Quigley will certainly participate in Sanofi coming from a San Francisco-based biotech that’s in secrecy, according to his LinkedIn profile. He is actually presently detailed as the company’s founder, head of state and also CEO.Considering that August 2021, Quigley has worked as a project companion at SV Health Investors, a healthcare fund supervisor along with existing expenditures in biotechs including BioAge, Cerevance, Dualitas Rehabs as well as Nimbus Therapeutics, to name a few. Quigley in the past held the top area at Dualitas, a biotech that continues to be in stealth, according to STAT.The future Sanofi innovator also recently helmed Therini Bio, an immunotherapy biotech working to build procedures for neurodegenerative illness steered through general dysfunction.Just before investing the final few years in biotech, Quigley possesses an even longer record in Big Pharma, very most lately working as Gilead’s elderly vice head of state of investigation biology until the summer of 2021.
Just before that, he appeared more than 4 years all over several leadership duties at Bristol Myers Squibb and functioned as a medical director at Johnson & Johnson’s Janssen upper arm prior to that.Sanofi claimed Quigley’s goal in his brand-new role would certainly be actually to “maximize our likelihood of excellence by means of optimum partnerships throughout our association and also beyond, taking best-in-class innovation and also creating as well as sourcing brand new industry-leading talent along with a dedication to range,” according to an interior memo obtained by STAT.